Dr Ram贸n Iglesias-Rey | neuroimaging | Best Researcher Award
聽 Miguel Servet Researcher at Health Research Institute of Santiago de Compostela (IDIS), Spain 馃帗
馃帗 Education
He earned a PhD in Materials Science (2013) and a Physics degree (2006) from the University of Santiago de Compostela.
馃彚 Work Experience
Dr. Iglesias has served as a postdoc and research assistant at the University of Santiago and held an international postdoctoral position in Finland (2015).
馃К Skills
He is skilled in molecular biology, MRI, and bioinstrumentation.
Awards and Honors 馃弳
He has multiple patents and co-developed the “Glutamate nanoprobe MR-agent.”
馃摎 Teaching Experience
Involved in mentoring students in neuroscience and bioengineering.
馃敩 Research Focus
馃摎 Publilcation聽
- Assessment of Mannitol-Induced Chronic Blood鈥揃rain Barrier Dysfunction In Vivo Using Magnetic Resonance
- Year: 2024
- Journal: International Journal of Molecular Sciences
- Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke
- Year: 2024
- Journal: International Journal of Molecular Sciences
- C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype
- Year: 2024
- Journal: Neurology
- Edoxaban Treatment in a Post-Infarction Experimental Model
- Year: 2024
- Journal: European Journal of Pharmacology
- How Can Radiomics Help the Clinical Management of Patients with Acute Ischemic Stroke?
- Year: 2023
- Journal: Applied Sciences
- Influence of Temperature Chronobiology on Stroke Outcome
- Year: 2023
- Journal: International Journal of Molecular Sciences
- Fibrin-Targeted Nanoparticles for Finding, Visualizing, and Characterizing Blood Clots in Acute Ischemic Stroke
- Year: 2022
- Journal: Pharmaceutics
- Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke
- Year: 2022
- Journal: Journal of Clinical Medicine